Proassurance CORP DEF 14A proxy statements

ProAssurance stockholders will receive $25 per share in cash as The Doctors Company acquires the company in a merger transaction.

ProAssurance details progress on its acquisition by The Doctors Company, including upcoming stockholder meetings and regulatory filings.

ProAssurance has agreed to be acquired by The Doctors Company, creating the second-largest medical malpractice insurance company in the US.

ProAssurance Corporation issues a supplement to its proxy statement to correct an error regarding the treatment of abstentions for two proposals at the upcoming Annual Meeting of Stockholders.

ProAssurance releases an updated FAQ for employees regarding the proposed acquisition by The Doctors Company, addressing questions about the transaction's impact on employment, benefits, and operations.

ProAssurance Corporation has filed a definitive proxy statement with the Securities and Exchange Commission.

ProAssurance Corporation announces its annual stockholders meeting to be held on May 21, 2025, to elect directors, ratify the appointment of auditors, and conduct an advisory vote on executive compensation, while a separate special meeting will address the proposed acquisition by The Doctors Company.

ProAssurance Corporation has entered into an agreement to be acquired by The Doctors Company, creating the second-largest medical malpractice insurance company in the United States.

ProAssurance Corporation issues a supplement to its definitive proxy statement to correct inaccuracies regarding outstanding shares and treasury shares as of the record date.

ProAssurance Corporation has filed a definitive proxy statement with the Securities and Exchange Commission.

ProAssurance Corporation is set to hold its annual meeting on May 22, 2024, featuring key proposals including the election of directors, approval of a new equity incentive plan, and ratification of independent auditors.